PFN4 is required for manchette development and acrosome biogenesis during mouse spermiogenesis

Naila Umer1, Sharang Phadke1, Farhad Shakeri2,3

  • 1Department of Developmental Pathology, Institute of Pathology, University Hospital Bonn, 53127 Bonn, Germany.

Development (Cambridge, England)
|August 11, 2022
PubMed

Insights

Profilin 4 (PFN4) deficiency severely impairs sperm manchette formation and acrosome biogenesis in mice. This leads to reduced motility and potential infertility, though zona-free oocyte fertilization remains possible.

Area of Science:

  • Reproductive Biology
  • Spermatogenesis
  • Molecular Cell Biology

Background:

  • Profilin 4 (PFN4) is crucial for sperm development, localizing to the acrosome-acroplaxome-manchette complex.
  • Understanding PFN4's role is vital for addressing male infertility.

Purpose of the Study:

  • To investigate the function of PFN4 in mouse spermatogenesis and sperm function.
  • To elucidate the molecular mechanisms underlying PFN4 deficiency-induced infertility.

Main Methods:

  • Generation of PFN4-deficient (Pfn4-/-) mice.
  • Sperm morphology, motility, and acrosome biogenesis analysis.
  • Immunofluorescence staining for key proteins (HOOK1, ARL3).
  • Proteomic analysis of testicular tissue.
  • In vitro fertilization assays.

Main Results:

  • Pfn4-/- sperm exhibit defective manchette formation, disrupted microtubular organization, and abnormal head/flagellar morphology.
  • Acrosome biogenesis is impaired due to disrupted Golgi networks and aberrant vesicle production.
  • Elevated levels of proteins involved in Golgi trafficking and PI3K/AKT pathway, alongside inhibited autophagy, were observed.
  • Pfn4-/- sperm can fertilize zona-free oocytes, indicating potential therapeutic applications.

Conclusions:

  • PFN4 is essential for proper manchette formation, sperm head shaping, and acrosome biogenesis during spermiogenesis.
  • PFN4 deficiency disrupts microtubular organization and Golgi function, leading to male infertility.
  • Targeting PFN4 pathways may offer novel strategies for treating human infertility.